Atossa Therapeutics
ATOS
#10745
Rank
NZ$36.45 M
Marketcap
NZ$3.65
Share price
2.55%
Change (1 day)
162.70%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): NZ-$7.02

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$7.43. In 2025 the company made an earnings per share (EPS) of NZ-$7.34 a decrease over its 2024 EPS that were of NZ-$5.53.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$7.02-4.36%
2025NZ-$7.3432.89%
2024NZ-$5.53-15.56%
2023NZ-$6.5414.29%
2022NZ-$5.7316.67%
2021NZ-$4.91-90.86%
2020NZ-$53.71-2.96%
2019NZ-$55.34-63.09%
2018NZ-$149.94-49.63%
2017NZ-$297.71-57.87%
2016NZ-$706.65-74.01%
2015NZ-$2,719-9.18%
2014NZ-$2,993-12.86%
2013NZ-$3,43570.73%
2012NZ-$2,01234.07%
2011NZ-$1,501263.41%
2010NZ-$412.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.14-263.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$18.50-348.90%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$22.30-400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$0.45-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.38-94.87%๐Ÿ‡บ๐Ÿ‡ธ USA